Inozyme Pharma Inc. (INZY:NASDAQ) soared at $5.96, a gain of 38.6%. On Mon, Apr 04, 2022, INZY:NASDAQ touched a New 2-Week High of $4.3. The stock appeared on our News Catalysts scanner on Mon, Apr 04, 2022 at 07:44 AM in the 'BIOTECH' category. From Tue, Mar 22, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Inozyme Pharma Inc. (INZY:NASDAQ)
Inozyme Pharma Inc is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and...
Top 10 Gainers:
- Anghami Inc. (ANGH:NASDAQ), 47.52%
- Dingdong (Cayman) Limited American Depositary Shares (each two representing three) (DDL:NYSE), 45.96%
- Inozyme Pharma Inc. (INZY:NASDAQ), 38.6%
- Tantech Holdings Ltd (TANH:NASDAQ), 31.26%
- Kaspien Holdings Inc. (KSPN:NASDAQ), 28.9%
- Celsion Corporation (CLSN:NASDAQ), 26.42%
- FG Financial Group Inc. (FGF:NASDAQ), 24.39%
- Poema Global Holdings Corp. (PPGH:NASDAQ), 23.69%
- System1 Inc. Class A (SST:NYSE), 23.02%
- Spirit Airlines, Inc. (SAVE:NYSE), 22.42%